Austin Hospital, Melbourne Australia | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1 / Phase 2	2026-06-26		NCT06157541
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study	Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, allergic asthma, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis	Recruiting	Not applicable	2026-05-06		NCT07055542
Acute Kidney Injury - Epidemiology in Intensive Care Unit Patients 2: an International Multicenter Cohort Study	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder	Enrolling by invitation	Not stated	2025-10-03		NCT07207031
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Recruiting	Not applicable	2022-06-23		NCT05136222